Browse Data and Analysis

Filter
Search Data and Analysis
Attaché Report (GAIN)

Sri Lanka: Agricultural Biotechnology Annual

Sri Lanka does not produce genetically engineered (GE) crops or animals. There is some GE research at the laboratory level, but there is no commercialization. The lack of a legal framework and biosafety procedures are a major setback; the country is in the process of finalizing regulatory biotechnology policies.
Attaché Report (GAIN)

Bulgaria: Agricultural Biotechnology Annual

The Government of Bulgaria (GOB) continues to oppose agricultural biotechnology and supports anti-biotech policy initiatives within the European Commission (EC). Non-governmental anti-biotech organizations, local activists, and Bulgaria’s organics industry actively spread nonscientific disinformation about biotechnology.
Attaché Report (GAIN)

South Korea: Agricultural Biotechnology Annual

Korea is in the process of revising its Living Modified Organism (LMO) Act. Once completed, these revisions will define Korea’s regulatory policies for products that utilize innovative technologies, including genome editing. Finalized changes to the LMO Act are expected by the end of 2022 with implementation planned for the end of 2023.
The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with the European Union’s regulations. Agricultural biotechnology is a disputed item in Ukraine. Currently, no GE events are officially approved for agricultural and food production.
Attaché Report (GAIN)

Burma: Agricultural Biotechnology Annual

This report describes the status of Burma’s production, regulations, public attitudes, trading, and labeling requirements for genetic engineered products and the current activities for agricultural biotechnology.
Attaché Report (GAIN)

Ghana: Agricultural Biotechnology Annual

Ghana’s National Biosafety Authority has eventually given the green light for the environmental release and placement on the market of the pod borer resistant (PBR) or Bt. Cowpea.
Egypt requires a biosafety legal framework. Without one, the country cannot move forward in the area of agricultural biotechnology. The absence of a legal framework impedes field trials, as well as the commercial use of genetically engineered (GE) crops.
Attaché Report (GAIN)

Thailand: Agricultural Biotechnology Annual

The Thai Cabinet has approved the draft Biodiversity Law in principle. The draft is in the legislative process and currently with the Council of State for review and approval on text. The Thai Food and Drug Administration finally published its two...
Attaché Report (GAIN)

Kazakhstan: Agricultural Biotechnology Annual

In the past year, there have been no major changes in Kazakhstan’s biotechnology policies, although the government may be making plans to regulate and commercialize agricultural biotechnologies. For the time being, Kazakhstan continues to rely on Eurasian Economic Union (EAEU) regulations for guidance on biotechnology issues.
Attaché Report (GAIN)

Turkey: Agricultural Biotechnology Annual

Turkey published its Biosafety Law and implementing regulations in 2010. This legislation has continued to disrupt trade and Turkey’s domestic agriculture and food sectors. The Ministry of Agriculture and Forestry is the sole authority for biotechnology approvals. The Ministry approved seven genetically engineered soybean and corn events in 2022.
Attaché Report (GAIN)

Japan: Agricultural Biotechnology Annual

This report provides the latest status of consumption, regulation, public perception, research, development, production, and use of agricultural biotechnology in Japan. Japan uses a science-based process for evaluating and granting approval for import and production of genetically engineered products.
Attaché Report (GAIN)

Israel: Agricultural Biotechnology Annual

As of September 2022, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology compared to 2021.